Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNOT7 | Q9UIV1 | 12/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | PARN | O95453 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7987237 | 0.93 | CNOT7 (0.57) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL7974538 | 0.92 | CNOT7 (0.57) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL7989411 | 0.89 | CNOT7 (0.53) | CNOT7ALDH1A1POLBPARN | |
| SCHEMBL7988946 | 0.88 | CNOT7 (0.56) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL7984710 | 0.87 | CNOT7 (0.55) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| Hydrochloric Acid SCHEMBL7984353 | 0.86 | CNOT7 (0.54) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL7974257 | 0.85 | CNOT7 (0.58) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL7987612 | 0.82 | CNOT7 (0.51) | CNOT7ALDH1A1POLBPARN | |
| SCHEMBL7988863 | 0.81 | CNOT7 (0.57) | CNOT7ALDH1A1KDM4ELMNAPOLB | |
| SCHEMBL7989567 | 0.81 | CNOT7 (0.50) | CNOT7ALDH1A1LMNAPOLBPARN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |